Guangdong Biolight Meditech Co., Ltd. (300246.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.14B
Enterprise Value2.27B
P/E Ratio-35.36
PEG Ratio0.86
Price/Sales Ratio3.38
Price/Book Ratio3.3
Enterprise/Revenue3.54
Enterprise/EBITDA-131.25

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.1
Operating Margin-0.09
AD

Management Effectiveness

Return On Assets-0.04
Return On Equity-0.09

Income Statement

Revenue1.1B
Revenue/Share4.16
Gross Profit281.53M
EBITDA27.35M
Net Income-69.43M
Diluted EPS-0.26

Balance Sheet

Total Cash606.75M
Total Cash/Share2.32
Total Debt753.22M
Total Debt/Equity0.68
Current Ratio1.44
Book Value Per Share4.53

Price History

52-Week Change56.52
52-Week High21.98
52-Week Low7.67
Moving Average 50 Days16.4
Moving Average 200 Days14.72

Statistics

Average Volume13.7M
Shares Outstanding264.61M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.05
Trailing Annual Dividend Yield0.36
Payout Ratio-0.23
Last Split Factor3:2
Last Split DateMay 25, 2023
AD